GenBody Inc.
PrivateLast Round
Corporate Funding
May 24, 2023
Est. Valuation
$132.74M
Total Funding Raised
$53.72M
Company Overview
GenBody Inc. operates in Healthcare & Life Sciences and is based in Cheonan-si. Its latest recorded funding round was a Corporate Funding round in May 2023.
GenBody Inc. is a diagnostic equipment company that develops, manufactures, and markets raw materials for diagnostic applications, ELISA, and rapid diagnostic tests for human and veterinary use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenBody Inc. Comparables
Compare GenBody Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ACON Laboratories, Inc. | 87% | |
| SD Biosensor Inc | 84% | |
| CorDx, Inc. | 82% |
For institutional investors. Book with your work email.
GenBody Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 24, 2023 | ||||
| Grant | Feb 1, 2021 | ||||
| Series B | Jan 1, 2017 | ||||
| Series A | Dec 1, 2016 | ||||
| Seed | Nov 1, 2015 |
For institutional investors. Book with your work email.
GenBody Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Series A, Series B |
| BNH INVESTMENT | Series A, Series B |
| NIH RADx | Grant |
| Kolon Investment | Series B |
| Shinhan Securities | Series B |
| NH Nonghyup Bank | Series B |
| Korea Investment & Securities | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2023
$1.51M raised in a corporate funding round.
- Jan 1, 2017
$37.2M round with participation from Kolon Investment.
For institutional investors. Book with your work email.
GenBody Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenBody Inc.'s valuation, stock price, and market status.
Is GenBody Inc. a public or private company?
GenBody Inc. is a private company.
What is the current stock price of GenBody Inc.?
GenBody Inc. is a private company, so its shares have no public market price. Caplight tracks GenBody Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenBody Inc. worth (valuation)?
GenBody Inc.'s valuation is estimated at $132.7M based on funding round data.
Can I buy GenBody Inc. stock?
GenBody Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenBody Inc.'s last funding round?
GenBody Inc.'s most recent funding round was Corporate Funding on May 24, 2023.
Who are the main investors in GenBody Inc.?
Key investors in GenBody Inc. include KOTEC, BNH INVESTMENT, NIH RADx, Kolon Investment, Shinhan Securities.
Will GenBody Inc. IPO soon?
No public IPO plans have been announced for GenBody Inc..
How can I track GenBody Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GenBody Inc.'s shares on secondary markets.